Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
Chiesa C, Mira M, Maccauro M, Romito R, Spreafico C, Sposito C, Bhoori S, Morosi C, Pellizzari S, Negri A, Civelli E, Lanocita R, Camerini T, Bampo C, Carrara M, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E. Chiesa C, et al. Among authors: mira m. Q J Nucl Med Mol Imaging. 2012 Dec;56(6):503-8. Q J Nucl Med Mol Imaging. 2012. PMID: 23358402 Free article.
Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C, Camerini T, Carrara M, Pellizzari S, Negri A, Aliberti G, Sposito C, Bhoori S, Facciorusso A, Civelli E, Lanocita R, Padovano B, Migliorisi M, De Nile MC, Seregni E, Marchianò A, Crippa F, Mazzaferro V. Chiesa C, et al. Among authors: mira m. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1718-1738. doi: 10.1007/s00259-015-3068-8. Epub 2015 Jun 27. Eur J Nucl Med Mol Imaging. 2015. PMID: 26112387
Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship.
Chiesa C, Mira M, Bhoori S, Bormolini G, Maccauro M, Spreafico C, Cascella T, Cavallo A, De Nile MC, Mazzaglia S, Capozza A, Tagliabue G, Brusa A, Marchianò A, Seregni E, Mazzaferro V. Chiesa C, et al. Among authors: mira m. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3018-3032. doi: 10.1007/s00259-020-04845-4. Epub 2020 May 25. Eur J Nucl Med Mol Imaging. 2020. PMID: 32451604
Radioembolization of Hepatocellular Carcinoma with 90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose-Response Analysis with Two Radiological Methods.
Romanò C, Mazzaglia S, Maccauro M, Spreafico C, Gabutti A, Maffi G, Morosi C, Cascella T, Mira M, De Nile MC, Aliberti G, Argiroffi G, Fuoco V, Bhoori S, Zanette C, Marchianò A, Seregni E, Mazzaferro V, Chiesa C. Romanò C, et al. Among authors: mira m. Cancers (Basel). 2022 Feb 15;14(4):959. doi: 10.3390/cancers14040959. Cancers (Basel). 2022. PMID: 35205712 Free PMC article.
Impact of missing attenuation and scatter corrections on 99m Tc-MAA SPECT 3D dosimetry for liver radioembolization using the patient relative calibration methodology: A retrospective investigation on clinical images.
Botta F, Ferrari M, Chiesa C, Vitali S, Guerriero F, Nile MC, Mira M, Lorenzon L, Pacilio M, Cremonesi M. Botta F, et al. Among authors: mira m. Med Phys. 2018 Apr;45(4):1684-1698. doi: 10.1002/mp.12774. Epub 2018 Feb 23. Med Phys. 2018. PMID: 29383733
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.
Alessi A, Lorenzoni A, Cavallo A, Padovano B, Iacovelli NA, Bossi P, Alfieri S, Serafini G, Colombo CB, Cicchetti A, Mira M, Licitra L, Fallai C, Crippa F, Orlandi E. Alessi A, et al. Among authors: mira m. Radiol Med. 2019 May;124(5):414-421. doi: 10.1007/s11547-018-0980-6. Epub 2018 Dec 17. Radiol Med. 2019. PMID: 30560502
253 results